RxDoctor Payments Data

Amit Patel, PA

Physician Assistant · Bel Air, MDNPI 1932330198

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $10,287 of the $11,828 with a category attached, or 87.0%. It is spread thinly across 48 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $3,733 and has fallen 50.6% since, to $1,843 in 2025. Among physician assistant clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,828in general payments, 2019–2025

Across 496 payments — averaging $23.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Relievant Medsystems, Inc.$1K
  • Collegium Pharmaceutical, Inc.$1K
  • Biohaven Pharmaceuticals, Inc.$1K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$780
  • Boston Scientific$654
  • plus $5K from 42 others

What the payments were for

  • Consulting fees$8007%
  • Travel & lodging$7416%
  • Food & beverage$10,28787%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,828 in reported general payments places this provider in the 95th percentile of 2,567 physician assistant providers in Maryland.

See all physician assistant providers in Maryland

Medicare billing

Part B allowed, 2024
$347,032
Medicare patients
394
Services billed
3,290

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelbucaBuprenorphine Hcl86$75,142
Xtampza ErOxycodone Myristate75$39,400
Diclofenac Sodium129$28,789
Buprenorphine112$28,327
MovantikNaloxegol Oxalate60$24,139
Nurtec OdtRimegepant Sulfate11$23,367
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen812$22,694
UbrelvyUbrogepant11$18,283
NucyntaTapentadol Hcl15$15,942
Oxycodone Hcl867$13,731
OxycontinOxycodone Hcl30$12,666
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen612$11,993
SymproicNaldemedine Tosylate27$11,975
LyricaPregabalin12$11,448
Lidocaine74$8,485

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er, Nucynta$1,032$130,484176 claims
PfizerNurtec Odt, Lyrica$562$34,81423 claims
Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate, Buprenorphine Hcl$15$32,605302 claims
Redhill Biopharma Inc.Movantik$157$24,13960 claims
AbbVieUbrelvy, Savella$2,011$23,37222 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,567 physician assistant providers in Maryland.

Other physician assistant in Bel Air

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →